Most nuclear medicine technologists are employed in hospital settings, where they contribute to the diagnosis and treatment.
Diagnostic nuclear medicine involves the use of radioactive tracers to image and/or measure the global or regional function of an organ. The radioactive tracer (radiopharmaceutical) is given to the ...
The general Nuclear Medicine program includes all areas of scintigraphic imaging, radionuclide therapy, use of radionuclides in the ascertainment of laboratory physiologic values, and proper ...
Two new PET radiotracers have outperformed the only current Food and Drug Administration (FDA) approved radiotracer for ...
What are the objectives of the Nuclear Medicine and Diagnostic Imaging Section? The long-term objective of the Section’s work is to provide comprehensive support to establish or strengthen the ...
Two new PET radiotracers have outperformed the only currently Food and Drug Administration (FDA) approved radiotracer for ...
The general Nuclear Medicine program includes all areas of scintigraphic imaging, radionuclide therapy, use of radionuclides in the ascertainment of laboratory physiologic values, and proper ...
The results of the studies indicate that the PET imaging agent may be a promising theranostic candidate for clinical use. The findings are published in the Journal of Nuclear Medicine. MTC is one ...
Trusted resource of information on Nuclear Medicine that includes articles, news, diet & nutrition, multimedia presentations, ...
Scientists have developed two new imaging agents that work better than the only currently approved one for detecting tau ...
PITTSBURGH, Jan. 8, 2025 /PRNewswire/ -- TTG Imaging Solutions, a leader in nuclear medicine and molecular imaging, announced a strategic milestone with its rebranding as Catalyst MedTech.